1. Home
  2. LSCC vs MDGL Comparison

LSCC vs MDGL Comparison

Compare LSCC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$114.61

Market Cap

12.6B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$517.83

Market Cap

12.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSCC
MDGL
Founded
1983
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
12.1B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
LSCC
MDGL
Price
$114.61
$517.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
12
Target Price
$103.75
$674.45
AVG Volume (30 Days)
1.6M
261.6K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.32
EPS
0.02
N/A
Revenue
$385,961,000.00
$180,133,000.00
Revenue This Year
$36.12
$58.39
Revenue Next Year
$19.98
$48.55
P/E Ratio
$5,726.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$43.90
$265.00
52 Week High
$126.35
$615.00

Technical Indicators

Market Signals
Indicator
LSCC
MDGL
Relative Strength Index (RSI) 57.86 53.05
Support Level $82.20 $503.93
Resistance Level N/A $539.17
Average True Range (ATR) 5.00 16.12
MACD -0.03 -3.62
Stochastic Oscillator 44.55 37.60

Price Performance

Historical Comparison
LSCC
MDGL

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: